Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study

Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation frequency on lung adenocarcinoma is still limited to retrospective studies. The PIONEER study (NCT01185314) is a prospective mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yuankai, Li, Junling, Zhang, Shucai, Wang, Mengzhao, Yang, Shujun, Li, Ning, Wu, Gang, Liu, Wei, Liao, Guoqing, Cai, Kaican, Chen, Liang’an, Zheng, Meizhen, Yu, Ping, Wang, Xiuwen, Liu, Yunpeng, Guo, Qisen, Nie, Ligong, Liu, Jiwei, Han, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657882/
https://www.ncbi.nlm.nih.gov/pubmed/26599344
http://dx.doi.org/10.1371/journal.pone.0143515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657882/
https://www.ncbi.nlm.nih.gov/pubmed/26599344
http://dx.doi.org/10.1371/journal.pone.0143515

Ejemplares similares